- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/22 - One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
Patent holdings for IPC class C07D 231/22
Total number of patents in this class: 174
10-year publication summary
14
|
9
|
14
|
13
|
8
|
10
|
8
|
5
|
8
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
BASF SE | 20458 |
15 |
Bayer AG | 3210 |
8 |
Bayer Cropscience AG | 2136 |
7 |
Takeda Pharmaceutical Company Limited | 2945 |
7 |
Laboratorios Del Dr. Esteve, S.A. | 208 |
7 |
Esteve Pharmaceuticals, S.A. | 218 |
6 |
The Johns Hopkins University | 5540 |
5 |
Sumitomo Pharma Co., Ltd. | 636 |
4 |
Bristol-myers Squibb Company | 4861 |
3 |
Sumitomo Chemical Company, Limited | 8997 |
3 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 66 |
3 |
Solvias AG | 43 |
3 |
Unimatec Co., Ltd. | 229 |
3 |
Theravance Biopharma R&D IP, LLC | 518 |
3 |
Metabomed Ltd. | 13 |
3 |
Janssen Pharmaceutica N.V. | 3610 |
2 |
Syngenta Crop Protection AG | 4922 |
2 |
Allergan, Inc. | 2431 |
2 |
ADAMA Makhteshim Ltd. | 477 |
2 |
Canadian Blood Services | 82 |
2 |
Other owners | 84 |